IL128345A - Enhanced contrast agent for ultrasound imaging of the liver - Google Patents

Enhanced contrast agent for ultrasound imaging of the liver

Info

Publication number
IL128345A
IL128345A IL12834597A IL12834597A IL128345A IL 128345 A IL128345 A IL 128345A IL 12834597 A IL12834597 A IL 12834597A IL 12834597 A IL12834597 A IL 12834597A IL 128345 A IL128345 A IL 128345A
Authority
IL
Israel
Prior art keywords
liver
contrast agent
ultrasound imaging
enhanced contrast
phospholipid
Prior art date
Application number
IL12834597A
Other languages
English (en)
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9616301.9A external-priority patent/GB9616301D0/en
Priority claimed from GBGB9705918.2A external-priority patent/GB9705918D0/en
Application filed by Amersham Health As filed Critical Amersham Health As
Publication of IL128345A publication Critical patent/IL128345A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
IL12834597A 1996-08-02 1997-08-04 Enhanced contrast agent for ultrasound imaging of the liver IL128345A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9616301.9A GB9616301D0 (en) 1996-08-02 1996-08-02 Improvements in or relating to contrast agents
GBGB9705918.2A GB9705918D0 (en) 1997-03-21 1997-03-21 Improvements in or relating to contrast agents
PCT/GB1997/002119 WO1998005364A2 (en) 1996-08-02 1997-08-04 Improvements in or relating to contrast agents

Publications (1)

Publication Number Publication Date
IL128345A true IL128345A (en) 2003-06-24

Family

ID=26309806

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12834597A IL128345A (en) 1996-08-02 1997-08-04 Enhanced contrast agent for ultrasound imaging of the liver
IL12934597A IL128345A0 (en) 1996-08-02 1997-08-04 Improvements in or relating to contrast agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL12934597A IL128345A0 (en) 1996-08-02 1997-08-04 Improvements in or relating to contrast agents

Country Status (16)

Country Link
US (1) US7892522B2 (cs)
EP (1) EP0918546B1 (cs)
JP (2) JP3634869B2 (cs)
KR (1) KR100593873B1 (cs)
CN (1) CN1104911C (cs)
AT (1) ATE411055T1 (cs)
AU (1) AU3780497A (cs)
CA (1) CA2262908A1 (cs)
CZ (1) CZ28999A3 (cs)
DE (1) DE69739047D1 (cs)
ES (1) ES2316157T3 (cs)
IL (2) IL128345A (cs)
MX (1) MXPA99001053A (cs)
NO (1) NO990276L (cs)
NZ (1) NZ334365A (cs)
WO (1) WO1998005364A2 (cs)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708246D0 (en) 1997-04-24 1997-06-18 Nycomed Imaging As Improvements in or relating to ultrasound imaging
GB9717589D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
US6548048B1 (en) 1998-04-28 2003-04-15 Amersham Health As Lipopeptide stabilized microbubbles as diagnostic/therapeutic agents
GB9809084D0 (en) * 1998-04-28 1998-06-24 Nycomed Imaging As Improvements in or relating to diagnostic/therapeutic agents
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
AU2003213730A1 (en) 2002-03-01 2003-09-16 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
AU2003278807A1 (en) 2002-03-01 2004-08-13 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
NO20024755D0 (no) * 2002-10-03 2002-10-03 Amersham Health As Metode
ES2352087T3 (es) * 2003-02-04 2011-02-15 Bracco Suisse Sa Agentes de contraste para ultrasonido y procedimiento para la preparación de los mismos.
EP2284180B1 (en) 2003-03-03 2015-09-09 Dyax Corp. Uses of peptides that specifically bind HGF receptor (cMET)
WO2005063305A1 (en) 2003-12-22 2005-07-14 Bracco Research Sa Gas-filled microvesicle assembly for contrast imaging
US8357351B2 (en) 2004-04-21 2013-01-22 Ananth Annapragada Nano-scale contrast agents and methods of use
US7713517B2 (en) 2004-04-21 2010-05-11 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
AU2005273865B2 (en) 2004-08-18 2011-02-24 Bracco Suisse S.A. Gas-filled microvesicles composition for contrast imaging
WO2006076826A1 (fr) * 2005-01-18 2006-07-27 Institute Of Pharmacology Toxicology, Academy Of Military Medical Sciences Composition de contraste pour ultrasons utilisant un phospholipide filmogene et procede de preparation de celle-ci
JP2006335745A (ja) * 2005-06-06 2006-12-14 Fujifilm Holdings Corp リポソームを含むｍｒｉ造影剤
CN100453050C (zh) * 2005-09-21 2009-01-21 北京市肿瘤防治研究所 提高超声造影图像分辨力的方法和超声造影成像仪
CA2947346C (en) 2005-12-09 2018-07-24 Bracco Suisse Sa Targeting vector-phospholipid conjugates
US20070140973A1 (en) * 2005-12-15 2007-06-21 Bristol-Myers Squibb Pharma Company Contrast agents for myocardium perfusion imaging
EP2217146A4 (en) 2007-12-05 2015-10-14 Marval Biosciences Inc NANOMETRIC SCALE CONTRAST AGENTS AND METHODS OF USE
WO2009152445A1 (en) * 2008-06-13 2009-12-17 Marval Biosciences, Inc. Imaging of atherosclerotic plaques using liposomal imaging agents
GB0811856D0 (en) * 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
WO2012136813A2 (en) 2011-04-07 2012-10-11 Universitetet I Oslo Agents for medical radar diagnosis
CN104349827A (zh) 2012-04-30 2015-02-11 通用电气医疗集团股份有限公司 向容器中灌装发泡组合物的方法
WO2014142927A1 (en) * 2013-03-14 2014-09-18 Empire Technology Development Llc Identification of surgical smoke
US10155063B2 (en) * 2015-11-12 2018-12-18 University Of Virginia Patent Foundation Methods for vas-occlusive contraception and reversal thereof
CN107233583B (zh) * 2016-03-29 2020-04-24 北京飞锐达医疗科技有限公司 一种具有超长持续时间的超声造影剂及其制备方法
US12383421B2 (en) 2017-01-05 2025-08-12 Contraline, Inc. Contraceptive devices
CN110381854A (zh) 2017-01-05 2019-10-25 考恩特兰有限公司 用于植入和逆转刺激响应性植入物的方法
WO2020102234A1 (en) 2018-11-13 2020-05-22 Contraline, Inc. Systems and methods for delivering biomaterials
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2129685B (en) * 1982-11-11 1985-11-13 Nat Biolog Standards Board Anti-haemophilic compositions
US5773024A (en) * 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
DE4100470A1 (de) * 1991-01-09 1992-07-16 Byk Gulden Lomberg Chem Fab Echokontrastmittel
IL113139A0 (en) * 1994-03-28 1995-06-29 Nycomed Imaging As Diagnostic compositions comprising imaging agents encapsulated in liposomes
US5540909A (en) * 1994-09-28 1996-07-30 Alliance Pharmaceutical Corp. Harmonic ultrasound imaging with microbubbles
NZ331509A (en) * 1996-02-19 2000-04-28 Nycomed Imaging As Aqueous dispersions of stabilised gas microbubbles and their use as contrast agents
IL125800A0 (en) * 1996-02-19 1999-04-11 Nycomed Imaging As Thermally stabilized contrast agent
US5837221A (en) * 1996-07-29 1998-11-17 Acusphere, Inc. Polymer-lipid microencapsulated gases for use as imaging agents
US6054118A (en) * 1997-01-22 2000-04-25 Nycomed Imaging As Contrast agents comprising two types of gas-containing microparticles

Also Published As

Publication number Publication date
WO1998005364A3 (en) 1998-06-18
WO1998005364A2 (en) 1998-02-12
KR20000029780A (ko) 2000-05-25
IL128345A0 (en) 2000-01-31
CN1227502A (zh) 1999-09-01
EP0918546B1 (en) 2008-10-15
CA2262908A1 (en) 1998-02-12
JP2000517296A (ja) 2000-12-26
MXPA99001053A (es) 2002-03-11
US7892522B2 (en) 2011-02-22
JP3634869B2 (ja) 2005-03-30
JP2004002453A (ja) 2004-01-08
NO990276D0 (no) 1999-01-22
NZ334365A (en) 1999-10-28
NO990276L (no) 1999-01-22
AU3780497A (en) 1998-02-25
KR100593873B1 (ko) 2006-07-03
CN1104911C (zh) 2003-04-09
DE69739047D1 (de) 2008-11-27
ES2316157T3 (es) 2009-04-01
ATE411055T1 (de) 2008-10-15
CZ28999A3 (cs) 1999-07-14
EP0918546A2 (en) 1999-06-02
US20020106328A1 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
IL128345A (en) Enhanced contrast agent for ultrasound imaging of the liver
WO1998038984A3 (en) Formulations for hydrophobic pharmaceutical agents
PH12012000094A1 (en) Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
AU2427601A (en) Radiation sensitive liposomes
PL347671A1 (en) Compounds and compositions for delivering active agents
PL339654A1 (en) Creation of peptide/lipide complexes by co-lyophilising process
FI971776A0 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
EP0993831A3 (en) Compounds and compositions for delivering active agents
CA2259179A1 (en) Emulsion formulations for hydrophilic active agents
IL124411A0 (en) Lipopolyamines as transfection agents and pharmaceutical uses thereof
MY118151A (en) Pharmaceutical formulations containing voriconazole.
DE69623087D1 (de) Brausemittel und dessen Herstellung
EP1900357A3 (en) Drug delivery system for hydrophobic drugs
AU6185398A (en) Charged lipids and uses for the same
PT975235E (pt) Formulacoes nutricionais contendo oligossacaridos
AU4786697A (en) Improvements in or relating to diagnostic/therapeutic agents
BE1014502A5 (fr) Compositions pharmaceutiques.
GR3020355T3 (en) Aminosulfonyl urea acat inhibitors
ZA963743B (en) Transdermal therapeutic system (TTS) for the administration of testosterone
RU94040150A (ru) Стабильная лиофилизированная композиция тиотепа, способ ее получения
GB9426484D0 (en) Compositions
WO2001040239A3 (en) Transition metal-cyclopentadienyl-tropane conjugates
NZ309125A (en) Improvements in or relating to contrast agents
AU1686397A (en) Modified avidin-type molecules as targeting agents for the liver and cells of the reticuloendothelial system
ES2070774A1 (es) Preparaciones liposomicas de farmacos o antigenos vacunales para medicina veterinaria.

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees
HC Change of name of proprietor(s)

Owner name: GE HEALTHCARE AS

Free format text: FORMER NAME:AMERSHAM HEALTH AS